The price-to-earnings ratio for CME Group Inc (NASDAQ: CME) is above average at 23.01x, Company’s 36-month beta value is 0.56.Analysts have differing opinions on the stock, with 5 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for CME is 358.88M, and currently, short sellers hold a 1.01% ratio of that floaft. The average trading volume of CME on November 06, 2024 was 1.80M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CME) stock’s latest price update
CME Group Inc (NASDAQ: CME)’s stock price has decreased by -2.85 compared to its previous closing price of 225.19. However, the company has seen a -3.74% decrease in its stock price over the last five trading sessions. prnewswire.com reported 2024-11-04 that Record October ADV for interest rate, energy, metals and agricultural products Record October ADV across U.S. Treasury and SOFR complexes All-time record monthly ADV in U.S. Treasury options and energy options CHICAGO, Nov. 4, 2024 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today reported its October 2024 market statistics, with average daily volume (ADV) reaching 24.3 million contracts, the second-highest October volume ever. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.
CME’s Market Performance
CME Group Inc (CME) has seen a -3.74% fall in stock performance for the week, with a -1.31% decline in the past month and a 6.64% surge in the past quarter. The volatility ratio for the week is 1.30%, and the volatility levels for the past 30 days are at 1.37% for CME. The simple moving average for the last 20 days is -2.97% for CME stock, with a simple moving average of 3.85% for the last 200 days.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with Redburn Atlantic repeating the rating for CME by listing it as a “Neutral.” The predicted price for CME in the upcoming period, according to Redburn Atlantic is $244 based on the research report published on October 08, 2024 of the current year 2024.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see CME reach a price target of $235. The rating they have provided for CME stocks is “Sector Perform” according to the report published on September 27th, 2024.
TD Cowen gave a rating of “Hold” to CME, setting the target price at $221 in the report published on September 26th of the current year.
CME Trading at -1.14% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.03% of loss for the given period.
Volatility was left at 1.37%, however, over the last 30 days, the volatility rate increased by 1.30%, as shares sank -1.61% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.59% upper at present.
During the last 5 trading sessions, CME fell by -4.12%, which changed the moving average for the period of 200-days by +6.83% in comparison to the 20-day moving average, which settled at $225.43. In addition, CME Group Inc saw 3.88% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from GEPSMAN MARTIN J, who sale 400 shares at the price of $222.92 back on Nov 04 ’24. After this action, GEPSMAN MARTIN J now owns 25,067 shares of CME Group Inc, valued at $89,168 using the latest closing price.
GEPSMAN MARTIN J, the Director of CME Group Inc, proposed sale 400 shares at $227.02 during a trade that took place back on Nov 01 ’24, which means that GEPSMAN MARTIN J is holding shares at $90,808 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.64 for the present operating margin
- 0.78 for the gross margin
The net margin for CME Group Inc stands at 0.57. The total capital return value is set at 0.1. Equity return is now at value 12.28, with 2.63 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.04. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is 96.92.
Currently, EBITDA for the company is 3.79 billion with net debt to EBITDA at 0.27. When we switch over and look at the enterprise to sales, we see a ratio of 13.22. The receivables turnover for the company is 9.6for trailing twelve months and the total asset turnover is 0.04.
Conclusion
In a nutshell, CME Group Inc (CME) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
